GlassScriptPhysician profile
Jennifer Brey
NPI 1285897637
$3,745.10
in general payments reported to CMS, 2019-2025
12 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $305 · 2021: $55.32 · 2022: $1,253 · 2023: $1,119 · 2024: $591 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,454 · Travel and Lodging: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,454.34 |
| Travel and Lodging | $520.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $2,413.58 | 2020-2024 | |
| Blue Surgical LLC | $402.00 | 2024-2025 | |
| Nuvasive Specialized Orthopedics, INC. | $265.48 | 2019-2023 | Precice Intramedullary Limb Lengthening System |
| Orthopediatrics Corp. | $235.23 | 2020-2023 | |
| Stryker Corporation | $193.97 | 2020-2024 | Axsos |
| Smith+Nephew, INC. | $80.76 | 2023 | Ultrabutton |
| Medtronic, INC. | $74.27 | 2024 | Shilla Growth Guidance System |
| Arthrex, INC. | $24.00 | 2023 | |
| Zimmer Biomet Holdings, INC. | $15.95 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $14.30 | 2019 | |
| Biomarin Pharmaceutical INC. | $13.82 | 2019 | |
| Medtronic USA, INC. | $11.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Brey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.